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Abstract
Introduction: To systematically review the literature onmother-to-child transmission in breastfed infants whosemothers received
antiretroviral therapy and support the process of updating the World Health Organization infant feeding guidelines in the context
of HIV and ART.
Methods: We reviewed experimental and observational studies; exposure was maternal HIV antiretroviral therapy (and
duration) and infant feeding modality; outcomes were overall and postnatal HIV transmission rates in the infant at 6, 9, 12
and 18 months. English literature from 2005 to 2015 was systematically searched in multiple electronic databases. Papers
were analysed by narrative synthesis; data were pooled in random effects meta-analyses. Postnatal transmission was
assessed from four to six weeks of life. Study quality was assessed using a modified Newcastle-Ottawa Scale (NOS) and
GRADE.
Results and discussion: Eleven studies were identified, from 1439 citations and review of 72 abstracts. Heterogeneity in
study methodology and pooled estimates was considerable. Overall pooled transmission rates at 6 months for breastfed
infants with mothers on antiretroviral treatment (ART) was 3.54% (95% CI: 1.15–5.93%) and at 12 months 4.23% (95% CI:
2.97–5.49%). Postnatal transmission rates were 1.08 (95% CI: 0.32–1.85) at six and 2.93 (95% CI: 0.68–5.18) at 12 months.
ART was mostly provided for PMTCT only and did not continue beyond six months postpartum. No study provided data on
mixed feeding and transmission risk.
Conclusions: There is evidence of substantially reduced postnatal HIV transmission risk under the cover of maternal ART.
However, transmission risk increased once PMTCT ART stopped at six months, which supports the current World Health
Organization recommendations of life-long ART for all.
Keywords: Antiretroviral therapy; HIV; prevention of mother-to-child transmission; breast feeding; systematic review; meta-
analysis
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Introduction
The annual number of new HIV infections in children has
decreased substantially, from an estimated 520,000 in 2000
to 220,000 in 2014, representing a 58% decline [1]. This
significant progress is consistent with improvements in the
coverage and quality of antiretroviral treatment (ART) pro-
grammes providing prevention of mother-to-child transmis-
sion and treatment of HIV-positive adults [2,3].
HIV transmission from mother to child can occur during
pregnancy, delivery, and breastfeeding [4]. Recognising the
substantial benefit of breastfeeding for infant health and
survival, and the need to minimise the risk of postnatal
transmission through breastfeeding [5–7], the 2010 World
Health Organization (WHO) guidelines recommended
breastfeeding for infants of HIV-positive mothers for at
least one year under the cover of maternal or infant
ART [8].
In most African countries and some parts of India, health
policy continues to advise mothers living with HIV to breast-
feed [9,10]. In such settings, exclusive breastfeeding (EBF)
for the first six months of life followed by complementary
feeding and continued breastfeeding (CBF) for up to one
year, under the cover of ART to either the mother or the
infant [6] is recommended. However, these recommenda-
tions were drawn up supported by limited information on
the risk of postnatal HIV transmission when women or child
or both were on ART to prevent mother-to-child transmis-
sion (PMTCT). In addition, there was little or no information
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on whether mixed feeding (MF), which had been associated
with increased risk of postnatal transmission in earlier stu-
dies, remained a risk even in the presence of ART [6,11].
In the past five years, further evidence has become avail-
able from studies and programmes where PMTCT postnatally
was achieved through maternal ART or infant prophylaxis. The
risk of transmission when infants receive other feeds in addi-
tion to breast milk in the first six months of life is of particular
interest for public health programmes [12]. To this end, we
present the results from a systematic review and GRADE
Evidence summary tables, addressing the question of HIV
transmission rates at six, nine, 12 and 18 months in infants
born to women who were on ART from early-mid pregnancy
until at least six months postpartum, and whose infants
breastfed in the first six months of life or longer. This study
was commissioned by the WHO and contributed to the for-
mulation of the 2016 WHO HIV Infant Feeding guidelines [13].
Methods
The review considered both experimental and observa-
tional studies, and included HIV- positive mothers receiving
ART and their breastfed children regardless of receipt of
infant antiretroviral prophylaxis. The exposures were HIV
antiretroviral therapy and feeding modality during breast-
feeding (EBF, MF, RF-replacement feeding) and outcome
measures were overall and postnatal HIV transmission
rate at six, nine, 12 and 18 months.
We conducted searches in multiple electronic databases
including PubMed, MEDLINE, EMBASE, Cochrane Central
Register of Controlled Trials, Web of Science, and CINAHL for
articles published between 2005 and 2015. As triple combina-
tion ART regimen were only introduced in public health pro-
grammes in 2004, we restricted the selection of studies to be
included in this review to publications from 2005. Reference
lists from relevant studies, grey literature and conference
abstracts available online from the International IAS AIDS
Conference in Melbourne 2014 and the 2013-2015
Conferences on Retroviruses and Opportunistic Infections
(CROI) were also searched.
Studies were first selected by SB and LC on the basis of
eligibility from their abstracts. Full text of selected studies was
then assessedwith disagreements between the two reviewers
resolved by a third reviewer (MLN). Data was extracted by SB
and revised by LC. We have used the reporting standards
described in the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement [14], and
the flow chart of the screening process is shown in Figure 1.
To obtain further information regarding infant feeding,
we contacted first authors of seven studies and received
responses from three of these, to solicit additional informa-
tion regarding infant feeding modality in the first six
months of life. Questions related to the type and duration
of recommended feeding practice, type of infant feeding
support provided to mothers, collection of data on child
feeding practices, and how this data was addressed in the
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Figure 1. Flowchart of screening process.
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study (proportion, statistical model, rates of transmission or
death).
Assessment of study quality
A modified Newcastle-Ottawa Scale (NOS) was developed
by the authors to assess the quality of all studies included
in the analysis, on the basis of selection of study partici-
pants and outcome assessment [15]. Each study could score
a maximum of five stars on Selection and four on Outcome;
considering representativeness of the study population,
ascertainment of exposure to ART and breastfeeding,
report of maternal adherence to ART and feeding modality.
The information obtained from the NOS was used to
comment on the quality of the included studies in the
Grading of Recommendations Assessment, Development
and Evaluation system (GRADE), a system for rating quality
of evidence and grading strength of recommendations in
systematic reviews [16]. In this study, GRADE considered
study limitations, consistency of results, directness, impre-
cision and reporting bias.
Results are presented narratively and as pooled esti-
mates with a heterogeneity score based on a random
effects meta-analysis using STATA 13 (Stata Corp, 2013).
Random effects were used because of methodological
differences among studies, such as rates of EBF, incen-
tives to keep treatment and time from which postnatal
transmission was ascertained, what allows the true trans-
mission rate to vary from study to study [17]. We sum-
marised the information in graphs depicting overall
(peripartum and postpartum transmission) and postnatal
(transmission after negative HIV test at four to six weeks)
HIV transmission rates at six and 12 months of age.
Where no confidence interval was available for estimates
from the study report, a confidence interval was calcu-
lated based on the number of events and those at risk
using the formula described by Eayres (2008, [18]).
Results
The search process identified 1439 citations, of which 1367
were excluded on the basis of being a duplicate, review,
qualitative study or not evaluating transmission at six, nine,
12 or 18 months according to feeding modality (Figure 1). The
abstracts of 72 studies were evaluated independently by three
researchers (SB, LC and ML), and 11 studies were finally
selected for inclusion in this review; four of these were
cohorts nested within randomised clinical trials [11,19–21]
and seven observational studies [5,22–27]. In all studies
mothers started ART before or during pregnancy, and contin-
ued until at least six months postnatally, according to the
WHO recommendations at the time. Seven studies followed
this recommendation [5,11,19,20,22–24] with six-month ART,
three provided lifelong ART for all women [21,25,26] while the
remaining study [27] provided lifelong ART only for treatment-
eligible mothers with very low CD4 count (see Supplementary
Table 1 for more details on included studies).
HIV transmission
Of the 11 studies, eight reported the transmission rate at
age six months [5,11,19,20,22,23,25,26]. Two studies
[19,26] did not provide a confidence interval around the
estimated transmission rate, which was calculated using the
formula [18]. Two studies reported the number of infec-
tions at six months and the number of children at risk: one
study [26] was a retrospective cohort and provided a single
number as a denominator (N = 856); and for the second
study [19] the number of children at risk was obtained from
the Kaplan-Meier graph. A further two studies reported the
number of transmissions but not the number of children at
risk [21,27] and one study reported transmission only at
age nine months, but noted that all transmissions occurred
during breastfeeding [24].
Overall transmission at age six months
For six studies overall transmission rates (including peripar-
tum) at age six months were provided [5,11,19,20,22,23]
(Figure 2A).
In two studies ART was provided since 15 weeks of
pregnancy [22,25]. Ngoma et al [25] reported three peri-
partum transmissions (before six weeks, number of children
at risk = 219), and no postnatal transmissions between six
weeks and six months, with an overall transmission rate at
six months of 1.4% (95% CI 0.5–3.9%). Marazzi et al. [22]
reported six transmissions at six months (N = 313, overall
transmission rate 1.9%, 95% CI 0.9–4.1%). Sagay et al. [26]
did not describe time for beginning of ART and a total of
four infections was reported at six months (N = 856; rate of
transmission was calculated as 0.5%, 95% CI 0.2–1.2%).
The subsequent studies started ART at later stages,
Jamieson et al [19] started ART before 30 weeks pregnancy,
and remaining studies started at 34 weeks pregnancy
[20,23]. Jamieson et al. [19] reported 67 infections; 21
infections after six weeks (N = 849; overall transmission
rate at age six months 7.9%, 95% CI 6.2–9.9%). Thomas
et al. [20] reported 24 transmissions, of which 20 occurred
before six weeks, for an overall transmission rate of 5.0%,
95% CI 3.4–7.4% (N = 487). Kilewo et al. [23] reported 22
infections at six months, 18 before six weeks (N = 423;
overall transmission rate 5.0%, 95% CI 2.9–7.1%).
The pooled estimate of overall transmission at six
months was 3.54% (95% CI 1.15–5.93%), with considerable
heterogeneity (I2 94.0%) (Figure 2A).
Postnatal transmission between four and six weeks and
six months
Six studies provided estimates of postnatal transmission
rates, excluding peripartum infections, diagnosed before
six weeks of age [5,11,19,20,22,23] (Figure 2B) and among
those, three studies provided ART since the first antenatal
visit [5,11,22]. Coovadia et al. [11] reported one infection
(N = 413, rate 0.2%; 95% CI 0–1.4%); Marazzi et al. [22]
provided the rate of transmission after four weeks of age
(2/313, rate 0.6%; 95% CI 0.2–2.3%). Alvarez-Uria et al. [5]
reported four (N = 127) infections for a transmission rate of
3.1% (95% CI 1.2–7.8%), noting that one of the infected
infants was mixed fed.
In the other three studies, Jamieson et al. [19] reported
21 infections (N = 769, rate 2.7%; 95% CI 1.80–4.10%);
Thomas et al. [20] and Kilewo et al. [23] did not provide a
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rate of postnatal transmission at six months, but the num-
ber of transmissions and number of children at risk were
reported. In each study there were four transmissions
between six weeks and six months of age (N = 482 for
Thomas et al., rate of postnatal transmission 0.80%, 95% CI
0.3–2.4%; and N = 418 for Kilewo et al., rate of postnatal
transmission 0.90%, 95% CI 0.3–2.1%). Figure 2B shows the
pooled estimate for these six studies, with a pooled trans-
mission rate of 1.08% (95% CI 0.32–1.85%). Heterogeneity
was substantial (I2 66.4%).
Two studies reported the number of infections at six
months but not the number of children at risk.
Thakwalakwa et al. [21] reported three infections before
six months (of 280 births but no information provided on
loss to follow up and deaths); Giuliano et al. [27] reported
four transmissions before six months, 288 children were
included in this study, but the number of children at risk of
transmission at six months was unclear.
Rate of transmission assessed after six months of age
Of the seven studies providing information on transmission
rates at age 12 months, five reported overall HIV transmission
rates [5,20,22,23,27] and two reported postnatal transmission
rates [11,19] (Figure 3). The pooled estimates showed an
overall rate of transmission at 12 months of 4.2% (95% CI
2.97–5.5%); and a postnatal transmission rate of 2.93% (95%
CI 0.68–5.18%) (Figure 3). Heterogeneity was higher in the
postnatal transmission (I2 71.2%) than in the overall HIV
transmission group (I2 39.9%). The postnatal pooled estimates
included only two studies, one in which mothers initiated ART
from first antenatal visit, and the other in which ART was
initiated until 30 weeks.
Peltier et al. [24] provided both overall and postnatal
transmission rate at nine months of age, with no transmis-
sion after cessation of breastfeeding. The total number of
children at risk was 227, with four infections (only one after
six weeks). The overall estimated rate of transmission at
nine months was 1.8% (95%CI 0.7–4.8%), and postnatal
0.5% (95% CI 0.1–3.4%). Only 15 mothers were reported
to have mixed fed their children, and none of these were
infected. Kilewo et al [23] also provided rate of transmis-
sion at 9 months, in which 23 children were infected
(N = 423), and five infections occurred after six weeks.
Overall transmission was 5.3% (95% CI 3.2–7.4%) and post-
natal transmission was 1.2% (95% CI 0.5–2.8%).
Four studies provided rate of transmission at 18 months,
but those could not be pooled due to high heterogeneity.
Ngoma et al. [25] was the only study which reported an
estimated overall rate of transmission at 18 months, with
lifelong ART provided for all mothers. Nine transmissions
were reported, with an overall transmission rate of 4.1%
(95% CI 2.2–7.6%; N = 219). Sagay et al. [26] also provided
mothers with lifelong ART, but the study was a retrospec-
tive cohort using the same denominator for all rates, what
does not allow for censoring due to loss to follow up or
death. The study reported two additional transmissions
after six months, and rate of transmission at 18 months
was estimated as 0.7%. Kilewo et al. [23] and Thomas et al.
[20] both provided overall transmission at 18 months, as
6.0% (95% CI 3.7–8.3%) and 6.7% (95% CI 4.8–9.4%)
Ngoma et al, 2015     (EBF:93%; N=219)
Sagay et al, 2015      (EBF:73%; N=856)
Jamieson et al, 2012  (EBF:89%; N=849)
Thomas et al, 2011    (EBF:89%; N=487)
Marazzi et al, 2009   (EBF:100%; N=313)
Kilewo et al, 2009     (EBF:80%; N=423)
Overall (I-squared=94%, p=0.000)
1.4 (0.5,3 .9)     16.7
0.5 (0.2, 1.2)     18.0
7.9 (6.2, 9.9)     16.4
5.0 (3.4, 7.4)     16.1
1.9 (0.9, 4.1)    16.8
5.0 (2.9, 7.1)     15.9
3.5 (1.2, 5.9)   100.0
Study  (Information)
%
Rate (95%CI)    Weight
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Thomas et al, 2011    (EBF:89%; N=482)
Marazzi et al, 2009    (EBF:100%; N=313)
Kilewo et al, 2009    (EBF:80%; N=418)
Overall (I-squared=66.4%, p=0.011)
0.2(0.0,1.4)     22.3
2.7(1.8,4.1)     17.0
3.1(1.2,7.8)     4.5
0.8(0.3,2.4)     18.1
0.6(0.2,2.3)     18.1
0.9(0.3,2.1)     19.92
1.1(0.3,1.9)     100.0
%
Rate (95%CI)   WeightStudy  (Information)
A) B)
Figure 2. Transmission rates at age six months: (a) overall transmission rate (including peripartum) at age six months; (b) postnatal
transmission rate between four and six weeks of age and age six months, with 95% confidence intervals, in children who were breastfed
and whose mothers were on ART.
Note: Red dashed lines represent final pooled estimate for overall (a) and postnatal (b) transmission rates.
(a) Sagay et al. (2015) and Jamieson et al. (2012) did not provide a rate of transmission, but the rate was calculated on the basis of the
number of children at risk provided in the paper. For Jamieson et al. (2012) transmission rate was provided at 28 weeks. For Ngoma et al.
(2015) and Marazzi et al. (2009), a confidence interval was not provided in the paper but calculated using the formula18.
(b) Coovadia et al. (2012), Alvarez-Uria et al. (2012), Thomas et al. (2011) and Kilewo et al. (2009) excluded positive children at six weeks.
Jamieson et al. (2012) excluded transmission at two weeks and Marazzi et al. (2009) excluded four weeks. Jamieson et al. (2012), Thomas
et al. (2011) and Kilewo et al. (2009) did not provide rate of transmission, but rate was calculated considering number of children at risk
provided in the paper.
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respectively. In both studies mothers started ART at
34 weeks gestation and stopped at six months postpartum.
Additional information regarding feeding
No study provided a transmission rate according to infant
feeding modality (EBF and MF); in all studies mothers were
recommended to (and assumed to have) exclusively
breastfed their infants for six months. Alvarez-Uria et al.
[5] noted that one of the infected children was mixed-fed,
but did not provide the rate of transmission by feeding
modality.
Additional information was asked from each study
regarding how feeding type was assessed and supported
during the study, with data also extracted from studies
(Table 1).
Grade profile
An evaluation of the quality of the studies considered in
this analysis is given in Supplementary Table 3. The assess-
ment of quality was based on study limitations/risk of bias
as per the evidence from the Newcastle-Ottawa Scale
(Supplementary Table 4). We also considered inconsistency,
indirectness and publication bias. All studies are rated very
low quality. Initially, all studies were scored low quality due
to being observational and were downgraded for indirect-
ness because their research areas were not directly in line
with the question. Where a pooled analysis was undertaken
and a pooled estimate provided, studies were further
downgraded for inconsistency if the heterogeneity was
not explained. In all groups of studies there was at least
one study with a risk of bias pertaining to lack of detailed
information on feeding leading to further downgrading as
did the substantial heterogeneity in transmission rate esti-
mates between studies.
Discussion
This systematic review is the first synthesis of the HIV
transmission risk in infants of HIV-positive mothers includ-
ing mothers receiving lifelong ART. The review provides
evidence for the low postnatal HIV transmission risk to
infants in the presence of maternal ART. We found a
pooled estimated rate of overall transmission by age six
months of 3.5% and a pooled postnatal transmission rate
by six months of age of 1.1% in women who were on ART
from early-mid pregnancy and who were recommended to
breastfed their infants for six months. The pooled estimate
for postnatal transmission at 12 months of age was 3.0%;
only one study provided an estimated rate of transmission
at 18 months, in women on lifelong ART, of 4.1%.
Our estimates compare favourably against estimates
from studies in the pre-ART era, ranging from 15% overall
transmission at six weeks [28] and 32% at six months
[29,30], highlighting the efficacy of ART in reducing trans-
mission risk following improved PMTCT services, adherence
to ART, and early initiation during pregnancy [2,31].
Exclusive breastfeeding to six months of life is recom-
mended for all infants because of its major effect on redu-
cing infant and child mortality and improving long-term
health outcomes. In the context of postnatal HIV transmis-
sion and before WHO guidelines recommending ART to
reduce postnatal transmission, refraining from mixed-feed-
ing in these first six months was also considered important
[12,32] because of the associated increased risk of
Figure 3. Transmission rates at 12 months of age, with 95% confidence intervals, in children who were breastfed and whose mothers
were on ART. Group 1: Overall transmission. Group 2: Postnatal transmission between four and six weeks and 12 months of age.
Note: Red dashed lines represent final pooled estimate for overall (a) and postnatal (b) transmission rates.
Coovadia et al (2012) excluded children HIV positive at six weeks. Jamieson et al. (2012) excluded transmission at two weeks. Marazzi et al.
(2009) did not provide the confidence interval, which was thus calculated using the formula18.
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postnatal transmission when compared to EBF [33–35].
However, we were unable to estimate the rate of transmis-
sion associated with MF, since no study provided this data.
Most studies included in this review assumed that mothers
exclusively breastfed up to six months as recommended [6],
however it has been reported by others that mixed feeding
before six months of age is common [12,36]. Kilewo et al.
[23] found that although at 16 weeks 80% of mothers were
still exclusively breastfeeding, this was only 51% at
24 weeks; in the Kisumo Breastfeeding Study [20] exclusive
breastfeeding at five months was 80.4%. EBF was found to
be more common in women of higher parity, and less
common in those not living with the child’s father [37]. In
a qualitative study in Nigeria investigating reasons for
mixed feeding, 42.8% of mothers reported pressure from
family members relating to infant feeding practice, with
28.5% following cultural practices, offering water and her-
bal medications to the child [38].
In the included studies, women were recommended to
exclusively breastfeed their infants for six months in line
with WHO guidelines, but there was no specific support
provided for mothers to exclusively breastfeed, and studies
did not collect detailed information on infant feeding mod-
ality. As such, findings from this review thus reflect real-life
situations. However, the reports from two studies included in
this systematic analysis shows that support may increase
adherence to exclusive breastfeeding. Marazzi et al. [22]
offered nutritional supplements to pregnant and lactating
women, and at each clinic visit, EBF counselling could be
emphasised; Ngoma et al. sent text messages and offered
food and transportation stipends to mothers participating in
the study [25]. Both studies had very high adherence to EBF,
with more than 90% of mothers reportedly exclusively breast-
feeding during the first six months.
WHO 2010 guidelines on HIV and infant feeding recommend
exclusive breastfeeding in the first six months of life primarily to
protect against other non-HIV infectious causes of infant mor-
tality. Based on the available evidence at that time, ART was
assumed to be effective at reducing HIV transmission risk in this
period. According to WHO guidelines, after six months, appro-
priate complementary food needs to be introduced while
breastfeeding continues, although currently HIV-positive
women are recommended to continue breastfeeding for one
year under the cover of ART [6,8]. Only two studies followed
the recommendation for HIV-positive women, with breastfeed-
ing up to 12 months postpartum and lifelong ART to mothers
[25,26]. In other studies mothers no longer received ART after
cessation of breastfeeding at six months, but there were
reported transmissions beyond six months due to continued
breastfeeding in the absence of ART cover [19,27]. Despite
providing lifelong ART and recommending breastfeeding up to
12 months, Ngoma et al. [25], reported high differences
between transmission rate at six months (1.4%) and 18months
(4.1%) due to poor adherence among mothers at taking ART.
They report that 11.4% ofwomenwhomissed a dispensary visit
transmitted HIV to the child, compared with 2.7% women who
did not miss any visit (p = 0.038). On the other hand, the
BREICHT study conducted in Malawi [21] found a very similar
rate of transmission between six and 12 months (three
infections before six months, four infections at 12 months,
N = 280). This result could be attributed to high adherence to
ART when it was given together with food supplements for the
child after six months, a strategy that proved to be feasible and
effective for improving retention in care.
This review highlighted the considerable clinical and
methodological heterogeneity in the studies due to differ-
ences in the time of ART initiation during pregnancy, the
recommended duration of breastfeeding, the age at
which infection in the infant was assessed, the details
on infant feeding modality and the definition of postnatal
transmission. In addition, we calculated transmission
rates and/or confidence intervals, where these were not
provided by all studies, which contributed to the low
quality of evidence for the estimated risk associated
with continued breastfeeding between six and 12 months
post-delivery. However, this systematic review and meta-
analysis which includes studies published between 2005
and 2015 informs our understanding of the risk of trans-
mission in the postnatal period in women who receive
ART. Although statistical inconsistency was considerable,
the trends were in the expected direction, and the find-
ings provide evidence for public health programmes as
well as for new MTCT guidelines.
Conclusion
The findings of this review demonstrate lower risk of post-
natal transmission when women are on ART and breastfeed-
ing, despite considerable heterogeneity in pooled analyses.
The overall quality of this evidence is low. The new WHO
guidelines on initiation of ART for all HIV-positive people
immediately upon the diagnosis of HIV infection will expand
ART coverage among HIV-positive pregnant and breastfeed-
ing women [13]. Our results suggest that will be important to
provide women with ongoing support to adhere to the WHO
EBF recommendations.
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